Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study
Buti, María, Manzano, María L, Morillas, Rosa M, García-Retortillo, Montserrat, Martín, Leticia, Prieto, Martín, Gutiérrez, María L, Suárez, Emilio, Gómez Rubio, Mariano, López, Javier, Castillo, Pilar, Rodríguez, Manuel, Zozaya, José M, Simón, Miguel A, Morano, Luis E, Calleja, José L, Yébenes, María, Esteban, Rafael
Published in PloS one (12.09.2017)
Published in PloS one (12.09.2017)
Get full text
Journal Article
Correction: Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study
Buti, María, Manzano, María L, Morillas, Rosa M, García-Retortillo, Montserrat, Martín, Leticia, Prieto, Martín, Gutiérrez, María L, Suárez, Emilio, Rubio, Mariano Gómez, López, Javier, Castillo, Pilar, Rodríguez, Manuel, Zozaya, José M, Simón, Miguel A, Morano, Luis E, Calleja, José L, Yébenes, María, Esteban, Rafael
Published in PloS one (25.06.2018)
Published in PloS one (25.06.2018)
Get full text
Journal Article